Abstract
Hepatocellular Carcinoma is one of the most common Cancers in adults. Sorafenib is the only drug available in the clinic in advanced stages, but many patients exhibit tumor progression during chemotherapy, which leads to the search for new treatments. The occurrence of the disease may be reduced and/or its development controlled by synergistic mechanisms in combination with diet bioactive…